Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
The Best 15 Applications for Efficiency and Association - 2Most loved Solace Food: What's Your Definitive Comfortable Dinner?
- 3Rick Steves Prefers Paying A Bit Extra For This Delectable Food When Dining In Spain
- 4Help Your Efficiency with These Work area Updates
- 5Miss Thailand Pageant Contestant's Veneers Fall Out During Speech on Stage
- 19 Strange Motion pictures You Shouldn't Watch With Your Mum
- Ocean side Locations for a Family Excursion
- Red Crescent: More than 100,000 civilian structures damaged in Iran
- Revealing the Incomparable Realms: An Excursion through Power and Inheritance
- 6 Useful Home Espresso Machines
- Germany expresses 'great concern' over Israel's new death penalty law
- 4 injured in shooting at North Carolina tree lighting ceremony
- 'Set up an Army Radio station at President’s Residence': Source close to Katz slams Herzog
- Ariana Grande says Eternal Sunshine 2026 tour will be her last for a 'long, long time': 'One last hurrah'
